Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DX25F6AGJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $7,572
Award facts
- Contract value 100% obligated
- $7,571.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,571.60 on September 18, 2025, for the supply of Nucala 100 mg/mL auto-injectors. The contract, which carries an ultimate completion date of September 19, 2025, is issued without a set-aside designation and is funded through the Medical Supply Chain division of the Defense Logistics Agency. This delivery order represents one of numerous pharmaceutical product awards issued to DMS Pharmaceutical Group, which maintains a significant single-award Indefinite Delivery Contract with the DLA under the SPE2DB program valued at $499.999 billion and valid through November 2026.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The Nucala auto-injector delivery supports military health facilities' medical supply requirements, reflecting the company's established portfolio of specialty pharmaceutical products ranging from oncology treatments to injectable medications and contraceptive devices. The firm fixed-price structure and compressed completion timeline indicate this is a routine procurement fulfilling immediate medical supply needs across the Defense Logistics Agency's healthcare distribution network.
Quick answers
Who was awarded contract SPE2DX25F6AGJ?
SPE2DX25F6AGJ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 18, 2025.
How much is contract SPE2DX25F6AGJ worth?
The government has obligated $7,572 on SPE2DX25F6AGJ.
Is contract SPE2DX25F6AGJ an order under another contract?
Yes. SPE2DX25F6AGJ is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AGJ competed?
The extent of competition for SPE2DX25F6AGJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award